WebMar 31, 2024 · Alimera Sciences, Inc. filed its 10-K on Mar 31, 2024 for the period ending Dec 31, 2024. In this report its auditor, Grant Thornton, gave an unqualified opinion expressing doubt that the company can continue as a going concern. WebFeb 22, 2024 · ATLANTA, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announces that its distribution partner, Horus Pharma S.A.S. (Horus) …
HOME - Alimera Sciences Inc.
Web12 Likes, 0 Comments - ️Тюль ️ Штори ️Індивідуальний пошив ️ (@premiumgardin.ua) on Instagram: "Гарна однотонна ... WebMar 27, 2024 · Alimera Sciences (ALIM) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. ghost river brewing memphis
Alimera Sciences Announces Third Quarter 2024 Financial Results
WebMar 31, 2024 · Alimera Sciences, Inc. meldete die Ergebnisse für das am 31. Dezember 2024 endende Geschäftsjahr. Für das Gesamtjahr meldete das Unternehmen einen Umsatz von 54,13 Mio. ... News auf Englisch zu ALIMERA SCIENCES, INC. 03.04. Alimera Announces Expansion of Agreement with Distribution Partner Horus Pharma to Incl.. AQ. … WebGet today's Alimera stock news. We cover the latest Alimera headlines and breaking news impacting Alimera stock performance. WebNov 4, 2024 · On November 2, 2024, J. Philip Jones resigned as Chief Financial Officer of Alimera Sciences, Inc. , effective November 28, 2024. In his role as Chief Financial Officer, Mr. Jones has served as the... March 23, 2024 ... All news about ALIMERA SCIENCES, INC. 06:11a: North American Morning Briefing: Traders Reassess -2-DJ. 03/16: North … front porch 4th of july decor